Press Release in connection with Un- Audited Financial Results of the Company for the Quarter Ended 30th June, 2026

Filed: 27 Jul 2026, 19:28 IST Exchange: BSE Category: Financial Results — Press Release

Press Release - Q1FY27 - Consolidated revenue ₹461 Cr (+25% q-q), EBITDA ₹121 Cr (+19% q-q), PAT ₹78 Cr (+20% q-q) - Volumes steady with 21,587 MT in Q1FY27; amines 6,249 MT, derivatives 8,205 MT, specialty chemicals 7,133 MT - Commissioned 100,000 TPA DME plant; expansion of N-Methyl Morpholine and Acetonitrile capacity planned in FY27 - Balaji Speciality Chemicals progressing ₹750 Cr expansion with new cyanide and EDTA products, commissioning expected FY27 - Confident in growth outlook backed by order pipeline, demand, and capacity additions

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 BALAMINES — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add BALAMINES to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Balaji Amines Limited

Important. The summary above is generated automatically from Balaji Amines Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.